---
title: "Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai Securities"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281701049.md"
description: "First Shanghai Securities analyst maintained a Buy rating on Sinopharm Group Co yesterday and set a price target of HK$26.70.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on Sinopharm Group Co is a Strong Buy with an average price target of HK$23.36."
datetime: "2026-04-05T05:16:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281701049.md)
  - [en](https://longbridge.com/en/news/281701049.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281701049.md)
---

# Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai Securities

First Shanghai Securities analyst maintained a Buy rating on Sinopharm Group Co yesterday and set a price target of HK$26.70.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Currently, the analyst consensus on Sinopharm Group Co is a Strong Buy with an average price target of HK$23.36.

### Related Stocks

- [01099.HK](https://longbridge.com/en/quote/01099.HK.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [200028.CN](https://longbridge.com/en/quote/200028.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [600511.CN](https://longbridge.com/en/quote/600511.CN.md)
- [000028.CN](https://longbridge.com/en/quote/000028.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)

## Related News & Research

- [Sinopharm Group Co (SHTDF) Gets a Buy from CLSA](https://longbridge.com/en/news/284466436.md)
- [Sinopharm subsidiary posts steady Q1 profit growth but cash flow weakens](https://longbridge.com/en/news/283669573.md)
- [Sinopharm posts unaudited Q1 2026 figures, highlighting RMB 400.8bn asset base](https://longbridge.com/en/news/284128644.md)
- [Grand Pharmaceutical Moves to Adopt New Bye-Laws Aligned With HK Paperless Regime](https://longbridge.com/en/news/284576690.md)
- [CSPC Innovation Posts Strong Revenue Growth but Wider Losses in Q1 2026](https://longbridge.com/en/news/284213122.md)